BioStem Technologies (BioStem Technologies) Market Cap : $104.80 Mil (As of May. 04, 2024)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioStem Technologies's share price for the quarter that ended in Sep. 2023 was $2.54. BioStem Technologies's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 13.49 Mil. Therefore, BioStem Technologies's market cap for the quarter that ended in Sep. 2023 was $34.27 Mil.

BioStem Technologies's quarterly market cap increased from Dec. 2022 ($36.36 Mil) to Mar. 2023 ($41.92 Mil) but then declined from Mar. 2023 ($41.92 Mil) to Sep. 2023 ($34.27 Mil).

BioStem Technologies's annual market cap declined from Dec. 2020 ($13.40 Mil) to Dec. 2021 ($12.15 Mil) but then increased from Dec. 2021 ($12.15 Mil) to Dec. 2022 ($36.36 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioStem Technologies's Enterprise Value for Today is $110.72 Mil.

BioStem Technologies Market Cap Historical Data

The historical data trend for BioStem Technologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Market Cap Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

25.94

23.13

13.40

12.15

36.36

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Market Cap	Get a 7-Day Free Trial															17.22	46.21	36.36	41.92	34.27

Competitive Comparison of BioStem Technologies's Market Cap

For the Biotechnology subindustry, BioStem Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioStem Technologies's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's Market Cap distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's Market Cap falls into.

BioStem Technologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

BioStem Technologies's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$2.99	*	12.161
	=	$36.36

BioStem Technologies's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )	=	Share Price (Q: Sep. 2023 )	*	Shares Outstanding (EOP) (Q: Sep. 2023 )
	=	$2.54	*	13.493
	=	$34.27

BioStem Technologies (OTCPK:BSEM) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

BioStem Technologies Market Cap Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.